Provenance du réseau au premier degré de Tomomi Ikemoto
Entité | Type d'entité | Industrie | |
---|---|---|---|
Spera Pharma, Inc.
Spera Pharma, Inc. Pharmaceuticals: MajorHealth Technology Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Tomomi Ikemoto via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ASTENA HOLDINGS CO., LTD. | Pharmaceuticals: Other | Comptroller/Controller/Auditor | |
Iwaki Seiyaku Co., Ltd.
Iwaki Seiyaku Co., Ltd. Pharmaceuticals: MajorHealth Technology Iwaki Seiyaku Co., Ltd. manufactures and sells pharmaceuticals. Its products include over-the-counter drugs, veterinary drugs, pharmaceutical intermediates, food additives, cosmetic raw materials, dyes, and pigment intermediates. The company was founded on January 28, 1931 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Japon | 4 |
Sectorielle
Health Technology | 4 |
Opérationnelle
Director/Board Member | 4 |
Comptroller/Controller/Auditor | 2 |
Corporate Officer/Principal | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Tomomi Ikemoto
- Connexions Sociétés